Results 61 to 70 of about 4,983 (214)

The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial

open access: yesScientific Reports, 2022
Women with chronic abnormal uterine bleeding-ovulatory dysfunction (AUB-O) are at increased risk of endometrial neoplasia. We conducted a non-inferiority randomized controlled trial to determine the effectiveness of two cyclic-progestin regimens orally ...
Nisarath Soontrapa   +7 more
doaj   +1 more source

URGENCY OF COMBINED ORAL CONTRACEPTIVES IN PROLONGED REGIMEN USE

open access: yesАкушерство, гинекология и репродукция, 2016
This article presents the issues on combined oral contraceptives use in prolonged regimen.
A. L. Tikhomirov, A. A. Ledenkova
doaj  

Medical treatment for adenomyosis: long term use of progestins

open access: yesGynecological Endocrinology
Background Adenomyosis is a uterine disorder causing menstruation-related symptoms such as dysmenorrhea, heavy menstrual bleeding (HMB) and dyspareunia. A long-term management of the disease is required.
Silvia Vannuccini   +8 more
doaj   +1 more source

The differential risk of oral contraceptives: the impact of full exposure history* [PDF]

open access: yes, 2017
Previous discussions have indicated that the small increases of risk of venous thromboembolism (VTE) associated with newer combined oral contraceptives (third generation, containing desogestrel and gestodene) may be attributed to bias due to cohort ...
Bruppacher, Rudolf   +5 more
core  

The social amplification of risk and the hazard sequence: The October 1995 oral contraceptive pill scare [PDF]

open access: yes, 2003
Hazard notifications routinely occur as part of the identification or management of a hazard. It is argued that a series of such notifications - a hazard sequence - may affect public responses to future notifications about that hazard and also that ...
Barnett, J, Breakwell, GM
core   +3 more sources

Hormone Profiles After Planned Low Energy Availability Exposure in Naturally Menstruating and Hormonal Contraceptive Using Physique Athletes

open access: yesEuropean Journal of Sport Science, Volume 25, Issue 12, December 2025.
ABSTRACT This observational study investigated the potential influence of hormonal contraceptive (HC) use on selected hormonal biomarkers (estradiol, total testosterone, IGF‐1, cortisol, triiodothyronine, and leptin) that respond to diet and physical training–induced low energy availability (LEA).
Ritva Mikkonen   +5 more
wiley   +1 more source

Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? [PDF]

open access: yes, 2013
Objective The primary aim of the study was to analyze the endometrioma recurrence rate in patients who under- went laparoscopic excision followed by postoperative long- term regimen of oral contraceptives (OCs).
Calagna, Gloria   +8 more
core   +1 more source

Uterine “twisting sign”: A new potential ultrasonographic soft marker for deep endometriosis

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1355-1363, December 2025.
Abstract Objective The objective of the current study was to evaluate the “twisting sign,” defined as uterine fundus rotation observed on transvaginal sonography (TVS), as a potential soft marker for deep endometriosis (DE) and its association with specific DE localizations and indirect signs.
Fabio Barra   +7 more
wiley   +1 more source

Há Mais “Vida” para Além da COVID-19

open access: yesGazeta Médica, 2022
A COVID-19 tornou-se a principal hipótese diagnóstica em muitas consultas. Este caso enaltece a necessidade de manter a abordagem holística, característica da Medicina Geral e Familiar.
Jaime Oliveira   +3 more
doaj   +2 more sources

EVOLUCIÓN A UN AÑO DE LOS EFECTOS ADVERSOS, EN UNA COHORTE DE PACIENTES CON IMPLANTE SUBDÉRMICO DE DESOGESTREL

open access: yesRevista Chilena de Obstetricia y Ginecología, 2006
Objetivo: El propósito de la investigación fue evaluar la evolución a un año los efectos adversos en una cohorte de pacientes con implante subdérmico de desogestrel. Método: Se incluyeron pacientes portadoras de implante que tenían como mínimo tres meses
Adolfo Patiño V   +5 more
doaj  

Home - About - Disclaimer - Privacy